Educational Webinar Invitation: Biologics and Biosimilars – An introduction from the pan-Canadian Oncology Biosimilars Initiative. Friday, June 21, 2019

Cancer Care Ontario (CCO) and the pan-Canadian Pharmaceutical Alliance (pCPA) are pleased to invite you to a 60-minute webinar entitled “Biologics and Biosimilars – An introduction from the pan-Canadian Oncology Biosimilars Initiative” on Friday, June 21, 2019 at 12:00 EST. 
 
In the 60-minute webinar, Sean Hopkins from Cancer Care Ontario will:  

  • Define biosimilar medications (Biosimilars)
  • Describe: 
    • How biologics and biosimilars are produced
    • Why there is inherent variability within and between them
    • How they are comparable to each other
  • Explain the regulatory approval process with respect to:  
    • Efficacy, and
    • Safety (Immunogenicity)  
  • State the regulations around extrapolation in Canada
  • Describe the implications to your clinical practice in terms of: 
    • Extrapolation, switching, clinical operations, and pharmacovigilance 

 
A question and answer period will follow the presentation. 
 
When: Friday, June 21, 2019 at 12:00 EST
 
Dial-in Details
Local Call-in: 416-620-7077   
Toll Free: 1-866-834-7685
Access Code: 0808025#
Weblink (to access presentation slides): https://cc.callinfo.com/r/1l9lov82hmy84&eom 

If you are unable to attend the live webinar, a recording of the presentation will be posted on CCO’s website. Please return to CCO’s website periodically and search “biosimilars” as the recording will be available after the live webinar.   
 
Please note that the webinar will be presented in English. We are working toward having the presentation available in French.
 
Sincerely,

Scott Gavura                                                               Imran Ali
Director, Provincial Drug Reimbursement Programs   Senior Manager 
Cancer Care Ontario                                                    pan-Canadian Pharmaceutical Alliance Office